HITK Financial Facts
Weighted average common shares outstanding-diluted: 13.73MNET INCOME: 5.94M
See Full Income Statement
Accrued expenses: 19.13M
TOTAL STOCKHOLDERS' EQUITY: 248.51M
See Full Balance Sheet
Earnings History for Hi Tech Pharmacal Co. Inc. (HITK)
|
Expand Research on HITK
| Next EPS Date | 4/8/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -17.3% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.6% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/13  |
 |
Q313 | $0.43 | $0.71 | -$0.28 | $64.33M | $60.45M | N/A / N/A | N/A | -9.9% | Details |
| 9/5/12 |
Q113 | $0.44 | $0.68 | -$0.24 | $52M | $57.6M | $0.74 / $58.28M | N/A | -7.4% | Details | |
| 3/8/12 |
|
Q411 | $0.79 | $0.87 | -$0.08 | $55.63M | $55.73M | N/A / N/A | N/A | -18% | Details |
| 7/10/12 |
|
Q412 | $0.73 | $0.78 | -$0.05 | $61.3M | $57.94M | $0.78 / $58.8M | N/A | +10.9% | Details |
| 12/6/12 |
|
Q213 | $0.66 | $0.59 | +$0.07 | $57.54M | $56.89M | N/A / N/A | N/A | +9% | Details |
| 3/10/11 |
|
Q311 | $0.79 | $0.63 | +$0.16 | $50M | $45.33M | N/A / N/A | N/A | +70.8% | Details |
| 12/9/10 |
|
Q210 | $0.76 | $0.56 | +$0.20 | N/A | N/A | N/A / N/A | N/A | +38.8% | Details |
| 9/7/11 |
|
Q112 | $1.05 | $0.84 | +$0.21 | $56.21M | $54.07M | N/A / N/A | N/A | +14.1% | Details |
